(3R,4R,5R)-3-Fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyloxolan-2-one
CAS: 879551-04-9
Ref. 3D-MF44944
1g | To inquire | ||
2g | To inquire | ||
5g | To inquire | ||
10g | To inquire | ||
25g | To inquire |
Product Information
- (2R) -2-Deoxy-2-fluoro-2-methyl-D- erythro- pentonic acid gamma-lactone2- Deoxy- 2- fluoro- 2- C- methyl- d- ribono- gamma- lactone (3R,4R,5R)-3-Fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyl-dihydrofuran-2(3H)-one
- (2R)-2-Deoxy-2-fluoro-2-methyl-<span class="text-smallcaps">D</span>-erythro-pentonic acid γ-lactone
- (3R,4R,5R)-3-Fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyldihydro-2(3H)-furanone
- 3-Fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyloxolan-2-one
- <span class="text-smallcaps">D</span>-erythro-Pentonic acid, 2-deoxy-2-fluoro-2-methyl-, γ-lactone, (2R)-
- D-erythro-Pentonic acid, 2-deoxy-2-fluoro-2-methyl-, ??-lactone
- D-erythro-Pentonic acid, 2-deoxy-2-fluoro-2-methyl-, gamma-lactone
(3R,4R,5R)-3-Fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyloxolan-2-one is a nucleoside that has been synthesized and characterized by x-ray crystallographic analysis. It is an analog of the nucleoside fluorouracil which has been fluorinated at the 5 position of the oxo group. The crystal structure of (3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyloxolan-2-one was determined using x ray crystallography to be a lactone with an anhydrous form. This compound is currently being investigated as a potential drug candidate for cancer treatment.
Chemical properties
Technical inquiry about: 3D-MF44944 (3R,4R,5R)-3-Fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyloxolan-2-one
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.